Stuart Snyder

Array ( [id] => 6080216 [patent_doc_number] => 20110142880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'LENTIVIRUS-BASED IMMUNOGENIC VECTORS' [patent_app_type] => utility [patent_app_number] => 12/934987 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18963 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142880.pdf [firstpage_image] =>[orig_patent_app_number] => 12934987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5342343 [patent_doc_number] => 20090180993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'ADMINISTRATION OF THERAPEUTIC VIRUSES' [patent_app_type] => utility [patent_app_number] => 12/409711 [patent_app_country] => US [patent_app_date] => 2009-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3669 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20090180993.pdf [firstpage_image] =>[orig_patent_app_number] => 12409711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992573 [patent_doc_number] => 20110014226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => ' HIGH THROUGHPUT PROTEIN INTERACTION ASSAY' [patent_app_type] => utility [patent_app_number] => 12/921890 [patent_app_country] => US [patent_app_date] => 2009-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15958 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014226.pdf [firstpage_image] =>[orig_patent_app_number] => 12921890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149312 [patent_doc_number] => 20110020907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'VIRUSES LACKING EPITHELIAL CELL RECEPTOR ENTRY' [patent_app_type] => utility [patent_app_number] => 12/933637 [patent_app_country] => US [patent_app_date] => 2009-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14659 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020907.pdf [firstpage_image] =>[orig_patent_app_number] => 12933637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148811 [patent_doc_number] => 20110020406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'VIRAL INACTIVATION PROCESS' [patent_app_type] => utility [patent_app_number] => 12/735957 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14974 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020406.pdf [firstpage_image] =>[orig_patent_app_number] => 12735957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174491 [patent_doc_number] => 20110177121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'Immunogenic Influenza Composition' [patent_app_type] => utility [patent_app_number] => 12/918487 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14425 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177121.pdf [firstpage_image] =>[orig_patent_app_number] => 12918487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153134 [patent_doc_number] => 08586034 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Cytomegalovirus disintegrin-like peptides' [patent_app_type] => utility [patent_app_number] => 12/369650 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13398 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12369650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538651 [patent_doc_number] => 20090220456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'USES OF INTERFERONS WITH ALTERED SPATIAL STRUCTURE' [patent_app_type] => utility [patent_app_number] => 12/369005 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17914 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220456.pdf [firstpage_image] =>[orig_patent_app_number] => 12369005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7703227 [patent_doc_number] => 08088982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications' [patent_app_type] => utility [patent_app_number] => 12/367824 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10702 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088982.pdf [firstpage_image] =>[orig_patent_app_number] => 12367824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232639 [patent_doc_number] => 07598064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Microfluidic device comprising electrolysis device for cell lysis and method for electrochemically lysing cells using the same' [patent_app_type] => utility [patent_app_number] => 12/349273 [patent_app_country] => US [patent_app_date] => 2009-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 7933 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598064.pdf [firstpage_image] =>[orig_patent_app_number] => 12349273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5533043 [patent_doc_number] => 20090232831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 12/338987 [patent_app_country] => US [patent_app_date] => 2008-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9271 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232831.pdf [firstpage_image] =>[orig_patent_app_number] => 12338987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6509563 [patent_doc_number] => 20100261156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'REAGENT FOR DETECTING HIV-1 ANTIGEN AND DETECTION METHOD' [patent_app_type] => utility [patent_app_number] => 12/745834 [patent_app_country] => US [patent_app_date] => 2008-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7976 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261156.pdf [firstpage_image] =>[orig_patent_app_number] => 12745834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9881983 [patent_doc_number] => 08968743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'Method and compositions for cutaneous immunisation' [patent_app_type] => utility [patent_app_number] => 12/745673 [patent_app_country] => US [patent_app_date] => 2008-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 8642 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12745673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5508047 [patent_doc_number] => 20090081254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'HIV VACCINE FOR MUCOSAL DELIVERY' [patent_app_type] => utility [patent_app_number] => 12/324933 [patent_app_country] => US [patent_app_date] => 2008-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9158 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20090081254.pdf [firstpage_image] =>[orig_patent_app_number] => 12324933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563686 [patent_doc_number] => 20090136538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Stable vaccine formulation' [patent_app_type] => utility [patent_app_number] => 12/323708 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9781 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136538.pdf [firstpage_image] =>[orig_patent_app_number] => 12323708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6602122 [patent_doc_number] => 20100322971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'METHOD FOR PRODUCING VACCINAL VIRAL STRAIN OF A VIRUS OF THE REOVIRIDAE FAMILY' [patent_app_type] => utility [patent_app_number] => 12/744041 [patent_app_country] => US [patent_app_date] => 2008-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 14449 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0322/20100322971.pdf [firstpage_image] =>[orig_patent_app_number] => 12744041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 224618 [patent_doc_number] => 07604801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-20 [patent_title] => 'Methods for detecting parvovirus infections' [patent_app_type] => utility [patent_app_number] => 12/252900 [patent_app_country] => US [patent_app_date] => 2008-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8463 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/604/07604801.pdf [firstpage_image] =>[orig_patent_app_number] => 12252900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500177 [patent_doc_number] => 20100215658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'VACCINIA VIRUS H3L AND B5R SPECIFIC MONOCLONAL ANTIBODIES AND METHODS OF MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 12/682539 [patent_app_country] => US [patent_app_date] => 2008-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 38240 [patent_no_of_claims] => 124 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215658.pdf [firstpage_image] =>[orig_patent_app_number] => 12682539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5403972 [patent_doc_number] => 20090239286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'PRODUCTION OF POXVIRUSES WITH ADHERENT OR NON ADHERENT AVIAN CELL LINES' [patent_app_type] => utility [patent_app_number] => 12/243437 [patent_app_country] => US [patent_app_date] => 2008-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13513 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239286.pdf [firstpage_image] =>[orig_patent_app_number] => 12243437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4532721 [patent_doc_number] => 07871807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Method for producing the flu virus' [patent_app_type] => utility [patent_app_number] => 12/238740 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 2 [patent_no_of_words] => 14162 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/871/07871807.pdf [firstpage_image] =>[orig_patent_app_number] => 12238740 [rel_patent_id] =>[rel_patent_doc_number] =>)